Knight Therapeutics (KHTRF) Q4 2024 Earnings

Nov 7Confirmed
Q4 2023
Q2 2024
Q3 2024
Q4 2024
-0.17
-0.11
-0.05
0.02

Details

Expected EPS
0.01299471615
Actual EPS
0
Surprise EPS
-0.01
Surprise Percent
-100%

Description

⁨Knight Therapeutics⁩ (⁦KHTRF⁩) has reported earnings of ⁦0⁩ per share for ⁦Q4 2024⁩.

0 Comments

Share your thoughts